Brain Cancer clinical trials in Florida

59 actively recruiting brain cancer trials at 26 sites across Florida.

Data from ClinicalTrials.gov · last refreshed 2026-07-27

Payments from drug makers to the doctors running these trials

For 2 of the trials on this page, the pharmaceutical company funding the trial also disclosed payments to the physicians leading it — public data from the federal CMS Open Payments database. Paying clinical-trial investigators for site work is expected and necessary for industry-funded trials; the scale and source are simply useful context when you're deciding whether to enroll.

Payments from the drug maker running this trial to its lead doctors

CMS Open Payments · 2024

Baptist Health South Florida funds and runs this clinical trial (NCT06048094). In 2024, Baptist Health South Florida reported paying the doctors leading the trial a total of $34,608 for research work on this study.

Who paid

Blue Earth Diagnostics Limited $34,608

Paid for research work on this trial

RUPESH KOTECHA(oncologist on CancerDrs) $34,608

Questions a patient might reasonably ask

Who is funding this trial, and how does the funding company stand to benefit if the trial succeeds?
Does my oncologist have a financial relationship with the trial sponsor outside of this trial?
Are there non-industry-sponsored trials (NIH, cooperative group) for my condition I should consider?
What are the alternative standards of care I should compare against enrolling here?

Research payments are not, by themselves, a conflict — paying for legitimate trial work is how drug development gets funded. The purpose of Sunshine Act disclosure is to give patients the context, not to make the decision for them.

Source: CMS Open Payments · ClinicalTrials.gov · Dispute process · How we compute this

As displayed on 2026-04-21. Corrections flow from the manufacturer through CMS and are adopted on our next refresh.

Payments from the drug maker running this trial to its lead doctors

CMS Open Payments · 2024

Baptist Health South Florida funds and runs this clinical trial (NCT04689048). In 2024, Baptist Health South Florida reported paying the doctors leading the trial a total of $65,964 for research work on this study.

Who paid

Blue Earth Diagnostics Limited $65,964

Paid for research work on this trial

RUPESH KOTECHA(oncologist on CancerDrs) $65,964

Questions a patient might reasonably ask

Who is funding this trial, and how does the funding company stand to benefit if the trial succeeds?
Does my oncologist have a financial relationship with the trial sponsor outside of this trial?
Are there non-industry-sponsored trials (NIH, cooperative group) for my condition I should consider?
What are the alternative standards of care I should compare against enrolling here?

Source: CMS Open Payments · ClinicalTrials.gov · Dispute process · How we compute this

As displayed on 2026-04-21. Corrections flow from the manufacturer through CMS and are adopted on our next refresh.

Phase 3 Recruiting Network

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

This trial has two cohorts of patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. All patients must be receiving trastuzumab-based treatment. Both cohorts are bei…

Sponsor: SWOG Cancer Research Network

NCT ID: NCT03418961

Sites in Florida:

Broward Health Medical Center — Fort Lauderdale, Florida
Mount Sinai Medical Center — Miami Beach, Florida
Moffitt Cancer Center — Tampa, Florida
Cleveland Clinic-Weston — Weston, Florida